Gesine Meyer-Rath
Profiles

Gesine Meyer-Rath, MD, PhD

Research Professor, Global Health - Boston University School of Public Health

(617) 414-1260
gesine@bu.edu
Crosstown Center
View Full Profile at BUMC

Biography

Prof Meyer-Rath is a Research Professor at the Department of Global Health of the Boston University School of Public Health. She is a physician and health economist working on the economics of HIV, TB and COVID-19 in low- and middle-income countries. Her focus lies on modeling methods for economic evaluation, including infectious disease modeling and decision analysis, and translating research into recommendations for public policy. Before joining BUSPH she has worked in the Pediatrics Department of Charité University Hospital Berlin, at the World Health Organization and at the London School of Hygiene and Tropical Medicine.

Prof Meyer-Rath is based in Johannesburg where she works at the Health Economics and Epidemiology Research Office (HE2RO), a collaboration between Boston University and the University of the Witwatersrand. She holds a PhD in Health Economics from the London School of Hygiene and Tropical Medicine as well as a MD/PhD in Physiology from Free University Berlin.

Education

  • Freie Universität Berlin, MD Field of Study: Medicine
  • Freie Universität Berlin, PhD Field of Study: Physiology

Websites

Publications

  • Published on 2/9/2026

    Bezuidenhout C, Long L, Nichols B, Meyer-Rath G, Fox MP, Theron G, Fourie B, Olifant S, Penn-Nicholson A, Ruhwald M, Medina-Marino A. Sputum and Tongue Swab Molecular Testing for the In-Home Diagnosis of Tuberculosis in Unselected Household Contacts: A Cost and Cost-Effectiveness Analysis. Clin Infect Dis. 2026 Feb 09; 82(1):49-57. PMID: 40705837.

     Read At: PubMed
  • Published on 2/1/2026

    Jamieson L, Rosen S, Meyer-Rath G, Mokhele I, Musakwa N, Imai-Eaton JW, Reed DM, Apollo T, Uetela DM, Shodell D, Ehrenkranz P, Fox MP. Age, sex-and what else? Rethinking priorities to close gaps in the HIV care cascade. J Int AIDS Soc. 2026 Feb; 29(2):e70080. PMID: 41664349.

     Read At: PubMed
  • Published on 1/7/2026

    Edoka I, Silal S, Jamieson L, Meyer-Rath G. Corrigendum to "A cost-effectiveness analysis of South Africa's COVID-19 vaccination programme" [Vaccine 42(20) (2024) 125988. Vaccine. 2026 Feb 27; 74:128162. PMID: 41505871.

     Read At: PubMed
  • Published on 11/10/2025

    Kusemererwa S, Nayiga B, Lebina L, Bekker LG, Philips A, Matharu LB, Govindasamy D, Meyer-Rath G, Kimbugwe G, Ruzagira E, Shahmanesh M, Seeley J, Webb EL, Fox J. Implementing oral (event-driven and daily) and long-acting pre-exposure prophylaxis in mobile men in sub-Saharan Africa: a phase 3b, open-label, hybrid type 2 implementation and effectiveness trial (MOBILE MEN). Trials. 2025 Nov 10; 26(1):486. PMID: 41214706.

     Read At: PubMed
  • Published on 11/1/2025

    Vesga JF, Mohamed MS, Shandal M, Jabbour E, Lomtadze N, Kubjane M, Trajman A, Meyer-Rath G, Avaliani Z, Rotich W, Mwai D, Croda J, Mathema HT, Kathure I, Pola R, Costa FD, Ndjeka NO, Danelia M, Tonini ML, Solomonia N, Pelissari DM, Falzon D, Miller C, Baena IG, Arinaminpathy N, Schwartzman K, Den Boon S, Campbell JR. The effectiveness, cost-effectiveness, budget impact, and return on investment of scaling up tuberculosis screening and preventive treatment in Brazil, Georgia, Kenya, and South Africa: a modelling study. Lancet Glob Health. 2025 Nov; 13(11):e1857-e1868. PMID: 41109257.

     Read At: PubMed
  • Published on 11/1/2025

    Meyer-Rath G, Jamieson L, Mudimu E, Snyman K, Ong JJ, Corlis J, Warren M, Wiseman V, Kripke K, Barnabas R, Phillips A, Head J, Stenberg K, Sully EA. Who pays and what pays off in sexual and reproductive health? A review of the cost and cost-effectiveness of interventions and implications for future funding and markets. Lancet. 2025 Nov 01; 406(10515):2152-2167. PMID: 41176394.

     Read At: PubMed
  • Published on 10/3/2025

    van Schalkwyk C, Meyer-Rath G, Masuku S, Jamieson L, Bloem P, Rangaraj A, Chidarikire T, Dlamini-Nqeteko S, Doherty M, Johnson LF, Dalal S. Corrigendum to "Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa" [Vaccine 64 (2025) 127770]. Vaccine. 2025 Oct 24; 65:127797. PMID: 41045635.

     Read At: PubMed
  • Published on 10/1/2025

    Stover J, Sonneveldt E, Tam Y, Horton KC, Phillips AN, Smith J, Martin-Hughes R, Ten Brink D, Citron DT, Kim HY, Akullian A, Mudimu E, Pickles M, Bershteyn A, Williamson J, Meyer-Rath G, Jamieson L, Sully EA, White JN, Heaton A, Clark RA, Tong H, Richards AS, McQuaid CF, Houben RMGJ, White RG, Dimitrov D, Kaftan D. Effects of reductions in US foreign assistance on HIV, tuberculosis, family planning, and maternal and child health: a modelling study. Lancet Glob Health. 2025 Oct; 13(10):e1669-e1680. PMID: 40975076.

     Read At: PubMed
  • Published on 9/22/2025

    van Schalkwyk C, Meyer-Rath G, Masuku S, Jamieson L, Bloem P, Rangaraj A, Chidarikire T, Dlamini-Nqeteko S, Doherty M, Johnson LF, Dalal S. Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa. Vaccine. 2025 Oct 03; 64:127770. PMID: 40992075.

     Read At: PubMed
  • Published on 8/21/2025

    Bezuidenhout C, Long L, Nichols B, Meyer-Rath G, Fox MP, Olifant S, Theron G, Fiphaza K, Pieruccini M, Ruhwald M, Penn-Nicholson A, Fourie B, Medina-Marino A. Using sputum and tongue swab specimens for in-home point-of-care targeted universal testing for tuberculosis of household contacts: an acceptability and feasibility analysis. BMJ Glob Health. 2025 Aug 21; 10(8). PMID: 40840972.

     Read At: PubMed

View 96 more publications:View Full Profile at BUMC

News & In the Media

View all profiles